Documents
Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | EQ 600MG BASE;EQ 50MG BASE;300MG | 1 | TRIUMEQ | ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE |
FDA Submissions
TYPE 4; Type 4 - New Combination | ORIG | 1 | AP | 2014-08-22 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2015-08-05 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2015-09-28 | STANDARD |
EFFICACY; Efficacy | SUPPL | 5 | AP | 2016-04-21 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 6 | AP | 2016-04-01 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2017-03-27 | STANDARD |
EFFICACY; Efficacy | SUPPL | 11 | AP | 2017-11-21 | PRIORITY |
LABELING; Labeling | SUPPL | 13 | AP | 2018-05-11 | STANDARD |
LABELING; Labeling | SUPPL | 14 | AP | 2018-09-06 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2018-09-06 | STANDARD |
LABELING; Labeling | SUPPL | 16 | AP | 2019-05-03 | STANDARD |
LABELING; Labeling | SUPPL | 21 | AP | 2020-03-24 | STANDARD |
LABELING; Labeling | SUPPL | 22 | AP | 2019-10-24 | STANDARD |
EFFICACY; Efficacy | SUPPL | 25 | AP | 2021-03-01 | STANDARD |
LABELING; Labeling | SUPPL | 26 | AP | 2021-03-23 | STANDARD |
EFFICACY; Efficacy | SUPPL | 28 | AP | 2022-03-30 | PRIORITY |
LABELING; Labeling | SUPPL | 29 | AP | 2022-10-07 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 4 | Null | 15 |
SUPPL | 5 | Null | 6 |
SUPPL | 6 | Null | 0 |
SUPPL | 10 | Null | 15 |
SUPPL | 11 | Null | 15 |
SUPPL | 13 | Null | 6 |
SUPPL | 14 | Null | 15 |
SUPPL | 15 | Null | 6 |
SUPPL | 16 | Null | 7 |
SUPPL | 21 | Null | 7 |
SUPPL | 22 | Null | 7 |
SUPPL | 25 | Null | 6 |
SUPPL | 26 | Null | 7 |
SUPPL | 28 | Null | 7 |
SUPPL | 29 | Null | 7 |
CDER Filings
VIIV HLTHCARE
cder:Array
(
[0] => Array
(
[ApplNo] => 205551
[companyName] => VIIV HLTHCARE
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/205551s022lbl.pdf#page=44"]
[products] => [{"drugName":"TRIUMEQ","activeIngredients":"ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE","strength":"EQ 600MG BASE;EQ 50MG BASE;300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"03\/24\/2020","submission":"SUPPL-21","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/205551s021lbl.pdf\"}]","notes":""},{"actionDate":"03\/24\/2020","submission":"SUPPL-21","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/205551s021lbl.pdf\"}]","notes":""},{"actionDate":"10\/24\/2019","submission":"SUPPL-22","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205551s022lbl.pdf\"}]","notes":""},{"actionDate":"10\/24\/2019","submission":"SUPPL-22","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205551s022lbl.pdf\"}]","notes":""},{"actionDate":"05\/03\/2019","submission":"SUPPL-16","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205551s016lbl.pdf\"}]","notes":""},{"actionDate":"05\/03\/2019","submission":"SUPPL-16","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205551s016lbl.pdf\"}]","notes":""},{"actionDate":"09\/06\/2018","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205551s014s015lbl.pdf\"}]","notes":""},{"actionDate":"09\/06\/2018","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205551s014s015lbl.pdf\"}]","notes":""},{"actionDate":"05\/11\/2018","submission":"SUPPL-13","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205551s013lbl.pdf\"}]","notes":""},{"actionDate":"05\/11\/2018","submission":"SUPPL-13","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205551s013lbl.pdf\"}]","notes":""},{"actionDate":"11\/21\/2017","submission":"SUPPL-11","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/205551s011lbl.pdf\"}]","notes":""},{"actionDate":"03\/27\/2017","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/205551s010lbl.pdf\"}]","notes":""},{"actionDate":"04\/21\/2016","submission":"SUPPL-5","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205551s005lbl.pdf\"}]","notes":""},{"actionDate":"09\/28\/2015","submission":"SUPPL-4","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205551s004lbl.pdf\"}]","notes":""},{"actionDate":"09\/28\/2015","submission":"SUPPL-4","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205551s004lbl.pdf\"}]","notes":""},{"actionDate":"09\/28\/2015","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205551s004lbl.pdf\"}]","notes":""},{"actionDate":"08\/05\/2015","submission":"SUPPL-2","supplementCategories":"Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205551s002lbl.pdf\"}]","notes":""},{"actionDate":"08\/05\/2015","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205551s002lbl.pdf\"}]","notes":""},{"actionDate":"08\/22\/2014","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/205551s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"08\/22\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 4 - New Combination","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/205551s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/205551Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2014\\\/205551Orig1s000TOC.cfm\"}]","notes":">"}]
[supplements] => [{"actionDate":"10\/24\/2019","submission":"SUPPL-22","supplementCategories":"Labeling-Package Insert, Labeling-Patient Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205551s022lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/205551Orig1s022ltr.pdf\"}]","notes":">"},{"actionDate":"03\/24\/2020","submission":"SUPPL-21","supplementCategories":"Labeling-Package Insert, Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/205551s021lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/205551Orig1s021ltr.pdf\"}]","notes":">"},{"actionDate":"05\/03\/2019","submission":"SUPPL-16","supplementCategories":"Labeling-Package Insert, Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205551s016lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/205551Orig1s016ltr.pdf\"}]","notes":">"},{"actionDate":"09\/06\/2018","submission":"SUPPL-15","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205551s014s015lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/205551Orig1s014s015REPLACEMENTLtr.pdf\"}]","notes":">"},{"actionDate":"09\/06\/2018","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205551s014s015lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/205551Orig1s014s015REPLACEMENTLtr.pdf\"}]","notes":">"},{"actionDate":"05\/11\/2018","submission":"SUPPL-13","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/205551s013lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/205551Orig1s013ltr.pdf\"}]","notes":">"},{"actionDate":"11\/21\/2017","submission":"SUPPL-11","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/205551s011lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/205551Orig1s011ltr.pdf\"}]","notes":">"},{"actionDate":"03\/27\/2017","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/205551s010lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/205551Orig1s010ltr.pdf\"}]","notes":">"},{"actionDate":"04\/01\/2016","submission":"SUPPL-6","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/21\/2016","submission":"SUPPL-5","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205551s005lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/205551Orig1s005ltr.pdf\"}]","notes":">"},{"actionDate":"09\/28\/2015","submission":"SUPPL-4","supplementCategories":"Labeling-Medication Guide, Labeling-Patient Package Insert, Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205551s004lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/205551Orig1s004ltr.pdf\"}]","notes":">"},{"actionDate":"08\/05\/2015","submission":"SUPPL-2","supplementCategories":"Labeling-Patient Package Insert, Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205551s002lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/205551Orig1s002ltr.pdf\"}]","notes":">"},{"actionDate":"06\/15\/2015","submission":"SUPPL-1","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-03-24
)
)